4 News & Press Releases found
MeMed News
-
Diasorin launches Liaison MeMed BV, the first high throughput blood test to differentiate between bacterial and viral infections, in countries accepting the CE Mark
Liaison Memed Bv is an immune system based protein signature test for distinguishing between bacterial and viral infections The test was developed following the licensing agreement signed with Memed as announced in September 2020 The new test is ...
-
Fierce Medtech names MeMed as one of its ‘Fierce 15’ medical technology companies
MeMed today announced that it has been named by Fierce Medtech as one of its ‘Fierce 15’ medical technology companies of 2021, designating it as one of the most promising private medtech companies in the industry. MeMed is a leader in ...
-
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
MeMed, a leader in host response technologies, today announces a $93 million private financing round, bringing total funding in the Company to over $200 million, including support from the U.S. Department of Defense and EU Commission. Funds will be ...
-
Clinical Data Published in Clinical Microbiology and Infection Support Use of MeMed’s Test in Reducing Antibiotic Overuse in Children
The study demonstrated the test’s high performance in distinguishing between bacterial and viral infection Incorporated a broad pediatric population presenting with fever without source and respiratory tract infection MeMed’s test ...